A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain.
A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain.
复制标题
DOI:
10.1016/j.cub.2014.01.013
复制
发表时间:
2014-03-03
期刊:
影响因子:
9.2
通讯作者:
Nitabach, Michael N.
中科院分区:
文献类型:
--
作者:
Gui, Junhong;Liu, Boyi;Cao, Guan;Lipchik, Andrew M.;Perez, Minervo;Dekan, Zoltan;Mobli, Mehdi;Daly, Norelle L.;Alewood, Paul F.;Parker, Laurie L.;King, Glenn F.;Zhou, Yufeng;Jordt, Sven-Eric;Nitabach, Michael N.
The venoms of predators such as spiders, scorpions, cone snails, sea anemones, and snakes, have been an excellent source of pharmacological diversity for drug discovery and as pharmacological tools for elucidating the structure, function, and physiological properties of ion channels. Here we describe the first known peptide antagonist of the nociceptor ion channel transient receptor potential ankyrin 1 (TRPA1). We constructed a recombinant cDNA library encoding ∼100 diverse GPI-anchored peptide toxins (t-toxins) derived from spider venoms and screened this library by co-expression in Xenopus oocytes with TRPA1. This screen resulted in identification of protoxin-I (ProTx-I), a 35-residue peptide from the venom of the Peruvian green-velvet tarantula, Thrixopelma pruriens, as the first known high-affinity peptide TRPA1 antagonist. Interestingly, ProTx-I was previously identified as an antagonist of voltage-gated sodium (NaV) channels. To identify the surfaces of ProTx-I by which it binds to these distinct ion channel types, we constructed a t-toxin library of ProTx-I alanine-scanning mutants and screened this library against NaV1.2 and TRPA1. This revealed distinct partially overlapping surfaces of ProTx-I by which it binds to these two ion channels, and whose specific chemical features explain its higher affinity for NaV1.2 than for TRPA1. Importantly, this mutagenesis yielded two novel ProTx-I variants that are only active against either TRPA1or NaV1.2, but not both. By testing its activity against chimeric channels, we identified the extracellular loops of the TRPA1 S1-S4 gating domain as the ProTx-I binding site. These studies establish screening of t-toxin libraries of native and mutated toxins, which we term “toxineering”, as a generally applicable method for isolation of novel ion channel modifiers and for design of ion channel modifiers with altered target selectivity. They also suggest that ProTx-I will be a valuable pharmacological reagent for addressing the biophysical mechanisms of TRPA1 gating, the physiology and pathophysiology of TRPA1 function in nociceptors, and for potential clinical application in the context of pain and inflammation.
登录
查看更多内容
DOI:
10.1523/jneurosci.5369-07.2008
发表时间:
2008-03-05
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Andersson DA;Gentry C;Moss S;Bevan S
通讯作者:
Bevan S
DOI:
10.1073/pnas.0812675106
发表时间:
2009-05-19
影响因子:
11.1
作者:
Andersson, David A.;Gentry, Clive;Bevan, Stuart
通讯作者:
Bevan, Stuart
影响因子:
15.9
作者:
Dai, Yi;Wang, Shenglan;Noguchi, Koichi
通讯作者:
Noguchi, Koichi
影响因子:
8
作者:
Chen, J.;Deng, M.;Liang, S.
通讯作者:
Liang, S.
影响因子:
15.9
作者:
Bessac, Bret F.;Sivula, Michael;Jordt, Sven-Eric
通讯作者:
Jordt, Sven-Eric